# LAKANA Sovereign Systems — Commercialization Pitch Deck

## 1. Opening Thesis
Raw state stays local. Only bounded truth moves.

LAKANA commercializes research into sovereign safety infrastructure by converting physics-bounded simulation evidence, deterministic governance logic, and role-scoped release methods into pilot-ready product pathways.

## 2. The Commercial Problem
Safety, sports performance, emergency coordination, and workforce monitoring tools often require continuous collection of location, biometric, identity, and incident context before value can be delivered.

This creates four buyer problems: adoption resistance, institutional liability, privacy exposure, and evidence-chain fragility.

## 3. LAKANA Contract
LAKANA reverses the default. Raw state remains local. TSARO governs admissibility. NICOLE governs custody, release, denial, and audit. Domain systems such as SSI, SOS, W-X, WX-Ag, and CivOS convert local context into bounded claim classes.

## 4. Research-to-Product Translation
Research asset → Product surface → Buyer value → Pilot artifact.

Monte Carlo simulations → evidence-bounded product claims → diligence confidence → result tables and artifact hashes.

Proof Theater → live interaction and scenario replay → buyer comprehension → exported session artifact.

TSARO/NICOLE governance → release discipline → lower exposure architecture → audit log and state matrix.

SSI athlete model → local structural state dashboard → sports/workforce safety pilot → role-scoped output demo.

SOS/CivOS continuity logic → degraded-condition safety workflow → municipal/community pilot → fail-closed scenario replay.

## 5. Commercial Pathway A — SSI
SSI targets athlete and load-bearing worker structural human-safety pilots. Initial partners include sports science labs, women’s athletics programs, occupational safety pilots, construction/logistics safety groups, and workforce resilience researchers.

The pilot package includes athlete edge dashboard, coach/supervisor bounded summary, governance-bound lease view, evidence boundary sheet, and exported review artifact.

## 6. Commercial Pathway B — SOS
SOS targets civilian safety and degraded-condition coordination pilots. Initial partners include university emergency management programs, municipal resilience groups, community safety research groups, field safety pilots, and preparedness organizations.

The pilot package includes degraded-field scenario replay, W-X context, TSARO admissibility state, NICOLE audit timeline, CivOS/SOS continuity map, and BFB bounded packet demonstration.

## 7. Commercial Pathway C — W-X / WX-Ag
W-X and WX-Ag commercialize as environmental truth and ground-state context layers. Their value is in freshness, uncertainty, source class, soil/water/field context, and physics-honest downstream decision boundaries.

Potential partners include agronomy research teams, weather resilience groups, field operations, climate-risk researchers, and infrastructure monitoring programs.

## 8. Productization Units
LAKANA can package commercialization through: pilot licenses, research partnership pilots, institutional demonstrators, SDK/API licensing for bounded state classes, embedded device/OEM integration, and evidence-governance review packages.

No pathway should imply medical-device status, field validation, emergency-service replacement, or security certification without separate validation.

## 9. Evidence Separation
Evidence page: Monte Carlo simulation results, retained-time contrasts, SSES metrics, SOS v71 basis, papers, artifacts, and claim boundaries.

Proof Theater: interactive live model, scenario replay, athlete dashboard, TSARO envelope, model bus, NICOLE log, export artifact.

Pitch page: commercial translation from research into pilots, buyer lanes, deployment packages, diligence path, and partnership motion.

## 10. Ask
LAKANA seeks pilots, research partners, commercialization mentors, non-dilutive funding support, and institutional reviewers who can evaluate bounded safety infrastructure without requiring raw-state extraction.

Public boundary: LAKANA public materials are simulation-stage and claim-bounded unless separately validated. They do not claim clinical validation, field validation, medical-device status, emergency-service replacement, production deployment, privacy/security certification, or guaranteed real-world performance.